Comparison of immunohistochemical profiles of ovarian germ cells in dysgerminomas of a captive maned wolf and domestic dogs

J Vet Diagn Invest. 2021 Jul;33(4):772-776. doi: 10.1177/10406387211019959. Epub 2021 May 28.

Abstract

We characterized the immunohistochemical expression profiles of dysgerminomas from a 16-y-old maned wolf and 13 domestic dogs using the following biomarkers: Sal-like protein 4 (SALL4), octamer-binding transcription factor 3/4 (OCT3/4), placental alkaline phosphatase (PLAP), c-kit, and vimentin. The maned wolf had nonspecific and long-standing clinical signs of lethargy, anorexia, and weight loss, and was euthanized because of poor prognosis. At autopsy, the left ovary was effaced by a 12 × 8 × 6 cm mass, comprised of anaplastic cells with a mitotic count of 20 mitoses in 10 high power fields. Dysgerminomas from 7 of 13 domestic dogs had nuclear expression of SALL4. Dysgerminomas from the maned wolf and 2 domestic dogs had both nuclear and cytoplasmic expression of SALL4. Cytoplasmic expression of PLAP and OCT3/4 was present in dysgerminomas from the maned wolf and 3 (PLAP) or 4 (OCT3/4) domestic dogs. All dysgerminomas expressed vimentin. Membranous c-kit expression was rare in the dysgerminoma from the maned wolf, and variable in dysgerminomas from 4 domestic dogs. A dysgerminoma from a domestic dog had cytoplasmic expression of c-kit. SALL4 is a useful marker to confirm germ cell origin of dysgerminoma in canids.

Keywords: Sal-like protein 4; canids; dysgerminoma; germ cell tumor; maned wolf.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Animals
  • Animals, Zoo
  • Biomarkers, Tumor / metabolism*
  • Brazil
  • Canidae*
  • Dog Diseases / diagnosis*
  • Dog Diseases / pathology
  • Dogs
  • Dysgerminoma / diagnosis
  • Dysgerminoma / pathology
  • Dysgerminoma / veterinary*
  • Female
  • Immunohistochemistry / veterinary
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / veterinary*
  • Ovary / pathology*

Substances

  • Biomarkers, Tumor